Cargando…
RNA Interference Therapy for Chronic Hepatitis B Predicts the Importance of Addressing Viral Integration When Developing Novel Cure Strategies
Chronic hepatitis B infection remains a globally important cause of morbidity and mortality and has recently undergone a renaissance in therapeutic interest with increased pre-clinical and clinical testing of new drug classes. One of the first new classes in the clinic was RNA interference agents, w...
Autores principales: | Wooddell, Christine I., Gehring, Adam J., Yuen, Man-Fung, Given, Bruce D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065501/ https://www.ncbi.nlm.nih.gov/pubmed/33808298 http://dx.doi.org/10.3390/v13040581 |
Ejemplares similares
-
RNA interference as a novel treatment strategy for chronic hepatitis B infection
por: Hui, Rex Wan-Hin, et al.
Publicado: (2022) -
Tickling the TLR7 to cure viral hepatitis
por: Funk, Emily, et al.
Publicado: (2014) -
RNA Interference Therapy With ARC‐520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection
por: Yuen, Man‐Fung, et al.
Publicado: (2020) -
The role of different viral biomarkers on the management of chronic hepatitis B
por: Mak, Lung-Yi, et al.
Publicado: (2023) -
HIV in the Brain: Identifying Viral Reservoirs and Addressing the Challenges of an HIV Cure
por: Ash, Michelle K., et al.
Publicado: (2021)